quinazolines has been researched along with 3-aminobenzamide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, YJ; Shacter, E | 2 |
Chalmers, A; Johnston, P; Joiner, M; Marples, B; Woodcock, M | 1 |
Gallmeier, E; Kern, SE | 1 |
Haince, JF; Hendzel, MJ; Masson, JY; Poirier, GG; Rouleau, M | 1 |
1 review(s) available for quinazolines and 3-aminobenzamide
Article | Year |
---|---|
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy.
Topics: DNA Repair; Gene Components; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Models, Molecular; Neoplasms; Phenanthrenes; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinazolines; Quinazolinones; Signal Transduction | 2005 |
4 other study(ies) available for quinazolines and 3-aminobenzamide
Article | Year |
---|---|
Oxidative stress inhibits apoptosis in human lymphoma cells.
Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Benzamides; Burkitt Lymphoma; Calcimycin; Caspase Inhibitors; Caspases; DNA Fragmentation; Etoposide; Humans; Hydrogen Peroxide; Oligomycins; Oxidative Stress; Protein Binding; Quinazolines; Quinazolinones; Tumor Cells, Cultured | 1999 |
Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo.
Topics: Adenosine Triphosphate; Apoptosis; Benzamides; Burkitt Lymphoma; Caspase 3; Caspases; Coumarins; Enzyme Activation; Humans; Hydrogen Peroxide; Oligopeptides; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Quinazolinones; Recombinant Proteins; Serine Proteinase Inhibitors; Tumor Cells, Cultured | 2000 |
PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation.
Topics: Animals; Benzamides; Cell Line; Cell Line, Tumor; Cell Survival; Cricetinae; Enzyme Inhibitors; Humans; Mice; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Stem Cell Assay | 2004 |
Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition.
Topics: Adenocarcinoma; Apoptosis; Benzamides; BRCA2 Protein; Enzyme Inhibitors; Frameshift Mutation; Humans; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2005 |